Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Left ventricular assist devices for destination therapy: OHTAC recommendation. Toronto: Health Quality Ontario (HQO). 2016 Authors' conclusions After a review of the evidence (1), OHTAC felt that the clinical benefit of LVADs as permanent
therapy for patients with end-stage heart failure, who are ineligible for heart transplantation,
outweighed its lack of cost-effectiveness. However, because there was uncertainty about this
treatment's effect on quality of life, OHTAC requested continued quality of life data collection to
be reviewed by OHTAC in two years. Indexing Status Subject indexing assigned by CRD MeSH Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5 Email: EDSinfo@hqontario.ca AccessionNumber 32016000558 Date abstract record published 22/03/2016 |